Pre-treatment T-cell subsets associate with fingolimod treatment responsiveness in multiple sclerosis

Biomarkers predicting fingolimod (FTY) treatment response in relapsing-remitting multiple sclerosis (RRMS) are lacking. Here, we performed extensive functional immunophenotyping using multiparametric flow cytometry to examine peripheral immune changes under FTY treatment and explore biomarkers of FT...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghadiri, Mahtab, Rezk, Ayman, Li, Rui, Evans, Ashley, Giacomini, Paul S., Barnett, Michael H., Antel, Jack, Bar-Or, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962338/
https://www.ncbi.nlm.nih.gov/pubmed/31941953
http://dx.doi.org/10.1038/s41598-019-57114-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962338/
https://www.ncbi.nlm.nih.gov/pubmed/31941953
http://dx.doi.org/10.1038/s41598-019-57114-2

Ejemplares similares